These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 11080454)

  • 41. Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes.
    Giegerich G; Pette M; Meinl E; Epplen JT; Wekerle H; Hinkkanen A
    Eur J Immunol; 1992 Mar; 22(3):753-8. PubMed ID: 1372258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis.
    Hong J; Zang YC; Tejada-Simon MV; Kozovska M; Li S; Singh RA; Yang D; Rivera VM; Killian JK; Zhang JZ
    J Immunol; 1999 Sep; 163(6):3530-8. PubMed ID: 10477628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP.
    Manoury B; Mazzeo D; Fugger L; Viner N; Ponsford M; Streeter H; Mazza G; Wraith DC; Watts C
    Nat Immunol; 2002 Feb; 3(2):169-74. PubMed ID: 11812994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells.
    Nag B; Kendrick T; Arimilli S; Yu SC; Sriram S
    Cell Immunol; 1996 May; 170(1):25-33. PubMed ID: 8660796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relative importance of individual DR binding motif positions as defined by peptide anchor analysis of influenza hemagglutinin peptide 306-318 and human myelin basic protein peptide 152-165 binding to several DR molecules: definition of a common extended DR binding motif.
    Posch PE; Hastings AE; Rosen-Bronson S; Richert JR; Hurley CK
    Eur J Immunol; 1996 Aug; 26(8):1884-91. PubMed ID: 8765035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity.
    Jingwu Z; Medaer R; Hashim GA; Chin Y; van den Berg-Loonen E; Raus JC
    Ann Neurol; 1992 Sep; 32(3):330-8. PubMed ID: 1384421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Localization of soluble major histocompatibility class II-peptide complexes on T cell surface.
    Arimilli S; Deshpande S; Nag B
    Microsc Res Tech; 2000 Sep; 50(5):419-24. PubMed ID: 10941178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
    Rich C; Link JM; Zamora A; Jacobsen H; Meza-Romero R; Offner H; Jones R; Burrows GG; Fugger L; Vandenbark AA
    Eur J Immunol; 2004 May; 34(5):1251-61. PubMed ID: 15114658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
    Pette M; Fujita K; Wilkinson D; Altmann DM; Trowsdale J; Giegerich G; Hinkkanen A; Epplen JT; Kappos L; Wekerle H
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7968-72. PubMed ID: 1700423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring myelin basic protein for HLA class I-binding sequences.
    Tanigaki N; Fruci D; Groome N; Butler RH; Londei M; Tosi R
    Eur J Immunol; 1994 Sep; 24(9):2196-202. PubMed ID: 7522167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.
    Li Y; Huang Y; Lue J; Quandt JA; Martin R; Mariuzza RA
    EMBO J; 2005 Sep; 24(17):2968-79. PubMed ID: 16079912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular interactions between transfected human TCR, immunodominant myelin basic protein peptide 152-165, and HLA-DR13.
    Hastings AE; Hurley CK; Robinson ED; Salerno K; Hernandez E; Richert JR
    J Immunol; 1996 Oct; 157(8):3460-71. PubMed ID: 8871645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120.
    Li H; Natarajan K; Malchiodi EL; Margulies DH; Mariuzza RA
    J Mol Biol; 1998; 283(1):179-91. PubMed ID: 9761682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein.
    Koehler NK; Yang CY; Varady J; Lu Y; Wu XW; Liu M; Yin D; Bartels M; Xu BY; Roller PP; Long YQ; Li P; Kattah M; Cohn ML; Moran K; Tilley E; Richert JR; Wang S
    J Med Chem; 2004 Oct; 47(21):4989-97. PubMed ID: 15456243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
    Kawamura K; Yamamura T; Yokoyama K; Chui DH; Fukui Y; Sasazuki T; Inoko H; David CS; Tabira T
    J Clin Invest; 2000 Apr; 105(7):977-84. PubMed ID: 10841661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.
    Muraro PA; Vergelli M; Kalbus M; Banks DE; Nagle JW; Tranquill LR; Nepom GT; Biddison WE; McFarland HF; Martin R
    J Clin Invest; 1997 Jul; 100(2):339-49. PubMed ID: 9218510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2.
    Mukku PV; Passmore D; Phan D; Nag B
    Mol Immunol; 1995 Jun; 32(8):555-64. PubMed ID: 7541890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
    Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
    J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
    Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
    Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.